Searching for pathogenic gene functions to cervical cancer

被引:43
作者
Ahn, WS
Bae, SM
Lee, JM
Namkoong, SE
Han, SJ
Cho, YL
Nam, GH
Seo, JS
Kim, CK
Kim, YW
机构
[1] Catholic Univ Korea, Canc Res Ctr, Catholic Res Inst Med Sci, Coll Med, Seoul 137040, South Korea
[2] Catholic Univ Korea, Dept Obstet & Gynecol, Coll Med, Seoul 137040, South Korea
[3] Chosun Univ, Dept Obstet & Gynecol, Coll Med, Kwangju 501759, South Korea
[4] Kyungpook Natl Univ, Dept Obstet & Gynecol, Taegu, South Korea
[5] Soonchunhyang Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea
[6] Seoul Natl Univ, Dept Biochem & Mol Biol, Seoul, South Korea
[7] Seoul Natl Univ, Coll Pharm, Seoul, South Korea
关键词
cervical neoplasia; cDNA microarray; Gene Ontology;
D O I
10.1016/j.ygyno.2003.11.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Molecular pathology of cervical cancers associated with human papillomavirus (HPV) infection is presently unclear. In an effort to clarify this issue, we investigated gene expression profiles and pathogenic cellular processes of cervical cancer lesions. Methods. Tissues of 11 patients (invasive cancer stages lb - IIIa) were investigated by a cDNA microarray of 4700 genes, hierarchical clustering and the Gene Ontology (GO). Results. We identified 74 genes showing a more than 2-fold difference in their expression in at least 8 out of 11 patients. Among these, 33 genes were up-regulated, in contrast, 41 genes were down-regulated. The gene expression profiles were classified into mutually dependent 345 function sets, resulting in 611 cellular processes according to the GO. The GO analysis showed that cervical carcinogenesis underwent complete down-regulation of cell death, protein biosynthesis, and nucleic acid metabolism. Also, genes belonging to nucleic acid binding and structural molecule activity were significantly down-regulated. In contrast, significant up-regulation was shown in skeletal development, immune response, and extracellular activity. Conclusion. These data suggest that the regulated genes and cellular processes could be further used for predicting prognosis and diagnosis of cervical cancer patients, and further investigation and functional characterization of the identified genes is warranted. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 46 条
  • [1] Abnormal expression of integrin alpha 6 beta 4 in cervical intraepithelial neoplasia
    Aplin, JD
    Dawson, S
    Seif, MW
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (02) : 240 - 245
  • [2] Gene Ontology: tool for the unification of biology
    Ashburner, M
    Ball, CA
    Blake, JA
    Botstein, D
    Butler, H
    Cherry, JM
    Davis, AP
    Dolinski, K
    Dwight, SS
    Eppig, JT
    Harris, MA
    Hill, DP
    Issel-Tarver, L
    Kasarskis, A
    Lewis, S
    Matese, JC
    Richardson, JE
    Ringwald, M
    Rubin, GM
    Sherlock, G
    [J]. NATURE GENETICS, 2000, 25 (01) : 25 - 29
  • [3] TGF-β and fibrosis
    Branton, MH
    Kopp, JB
    [J]. MICROBES AND INFECTION, 1999, 1 (15) : 1349 - 1365
  • [4] Dual function of the epithelial specific ets transcription factor, ELF3, in modulating differentiation
    Brembeck, FH
    Opitz, OG
    Libermann, TA
    Rustgi, AK
    [J]. ONCOGENE, 2000, 19 (15) : 1941 - 1949
  • [5] Diindolyl methane alters gene expression in human keratinocytes in vitro
    Carter, TH
    Liu, K
    Ralph, W
    Chen, DZ
    Qi, M
    Fan, SJ
    Yuan, F
    Rosen, EM
    Auborn, KJ
    [J]. JOURNAL OF NUTRITION, 2002, 132 (11) : 3314 - 3324
  • [6] Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18
    Cho, YS
    Kang, JW
    Cho, M
    Cho, CW
    Lee, S
    Choe, YK
    Kim, Y
    Choi, I
    Park, SN
    Kim, S
    Dinarello, CA
    Yoon, DY
    [J]. FEBS LETTERS, 2001, 501 (2-3) : 139 - 145
  • [7] Cluster analysis and display of genome-wide expression patterns
    Eisen, MB
    Spellman, PT
    Brown, PO
    Botstein, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) : 14863 - 14868
  • [8] Gao AC, 1999, PROSTATE, V38, P46, DOI 10.1002/(SICI)1097-0045(19990101)38:1<46::AID-PROS6>3.0.CO
  • [9] 2-9
  • [10] Girault I, 2003, CLIN CANCER RES, V9, P4415